Pharmaceutics, Volume 9, Issue 4
2017 December - 23 articles
Cover Story: Nanoparticle technology has permitted the exploration of many new avenues in parenteral and nonparenteral drug delivery, not only intravenous but also oral, topical, ocular, respiratory and mucosal. Mucosal drug delivery with nanoparticles may be facilitated by chitosan nanoparticles by virtue of chitosan’s Ph-dependent solubility, positive charge which aids binding to mucous, and the evolution of improved drug loading methodologies. This has permitted a greatly expanded scope of potential clinical applications for polymeric nanoparticles by the nonparenteral routes of administration. This review discusses not only these applications but also the technical aspects of nanoparticle fabrication. View this paper - Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
- You may sign up for email alerts to receive table of contents of newly released issues.
- PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.